Overall hemostatic potential

Source: Wikipedia, the free encyclopedia.
Overall hemostatic potential
hypocoagulability, hemostasis, fibrinolysis

The overall hemostatic potential (OHP) test is a

procoagulant, anticoagulant, and fibrinolytic factors.[1]

The OHP is a technically simple

transgender women.[5] However, more studies are needed to validate the test as a biomarker of thrombosis and other abnormalities of coagulation.[2][3][4]

History

The original OHP assay was developed in Sweden by Blombäck and colleagues and was first described in 1999.[1][6][7] It used thrombin to trigger coagulation.[1] Since then, a modified version has been developed which can use either thrombin or tissue factor to trigger coagulation.[1][3][8][9]

References

  1. ^
    PMID 28804852
    .
  2. ^ .
  3. ^ .
  4. ^ .
  5. .
  6. .
  7. .
  8. .
  9. ^ Curnow, J. L. (2010). Evaluation of the overall haemostatic potential assay for the diagnosis and management of hypercoagulable states (Doctoral dissertation, University of Sydney). https://scholar.google.com/scholar?cluster=17586055299192023070